Announced Thu, 25 Jun · 12:28 IST

39th AGM held; Capital Reduction and MD appointment approved

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Novyra Pharmachem (formerly Bansisons Tea Industries) held its 39th AGM on June 25, 2026 via video conferencing from 11:00 AM to 11:30 AM. Five resolutions were passed including adoption of FY26 audited financials (audit report had no qualifications), re-appointment of Sandeep Agarwal as director retiring by rotation, a special resolution on capital reduction, and regularization plus appointment of Anilkumar Amreliya as Managing Director. No shareholders raised queries. E-voting results will be announced within 48 hours.

Likely market impact

Capital reduction and new MD appointment point to corporate restructuring; await voting outcome within 48 hours for confirmation.